Literature DB >> 10401952

Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine--a case report.

I Granier1, E Garcia, A Geissler, M D Boespflug, J Durand-Gasselin.   

Abstract

Cerebral angiopathy of the postpartum period is a rare entity, sometimes promoted by vasoconstrictives drug prescription. Its clinical presentation includes headaches, seizures and focal neurological deficits, which develop shortly after a normal pregnancy. The diagnosis is based on clinical findings and angiography, showing multiple narrowing of the intracranial cerebral arteries. This neurological feature is reversible and the clinical outcome is good. We report a case of benign cerebral angiopathy in a 20-year-old woman in the postpartum period, occurring after administration of sumatriptan and ergot derivates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401952     DOI: 10.1007/s001340050894

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  Pregnancy and stroke.

Authors:  Mohammed Pathan; Steven J Kittner
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

Review 3.  Clinically significant drug interactions with agents specific for migraine attacks.

Authors:  M J Eadie
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

5.  Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage.

Authors:  Brian L Edlow; Scott E Kasner; Robert W Hurst; John B Weigele; Joshua M Levine
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

6.  Khat - a new precipitating factor for reversible cerebral vasoconstriction syndrome: a case report.

Authors:  Harith Baharith; Amy Zarrin
Journal:  J Med Case Rep       Date:  2016-12-15

Review 7.  Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.

Authors:  Yuji Kato; Takeshi Hayashi; Satoko Mizuno; Yohsuke Horiuchi; Masayuki Ohira; Norio Tanahashi; Masaki Takao
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.